3-methyl-4-pyranone | 50671-50-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃
• 英文名称: 3-methyl-4-pyranone
• 英文别名: 3-Methyl-pyron-(4)；3-methyl-pyran-4-one；3-Methyl-pyran-4-on；3-Methyl-4H-pyran-4-one；3-methylpyran-4-one
• CAS: 50671-50-6
• 化学式: C₆H₆O₂
• 分子量: 110.112
• InChiKey: MFVPQWUCDQVFPS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  碘甲烷 、 alkaline earth salt of/the/ methylsulfuric acid 在 甲醇 作用下， 生成 3-methyl-4-pyranone
  参考文献：
  名称：

  Willstaetter; Pummerer, Chemische Berichte, 1905, vol. 38, p. 1469

  摘要：

  DOI：

文献信息

• [EN] METHODS FOR HYDRAULIC ENHANCEMENT OF CROPS<br/>[FR] PROCÉDÉS DE STIMULATION HYDRAULIQUE DES CULTURES
  申请人：ASILOMAR BIO INC

  公开号：WO2016172655A1

  公开（公告）日：2016-10-27

  Disclosed herein are compounds, salts, solvates of Formula (1), and any formulation thereof. Also disclosed are methods of eliciting hydraulic enhancement and/or increasing yield of a plant by contacting a plant with compounds, salts, solvates of Formula (1), or any formulation thereof.

  本文披露了化合物、盐、溶剂化合物的化合物（1）及其任何配方。还披露了通过将植物与化合物、盐、溶剂化合物的化合物（1）或其任何配方接触来引发水力增强和/或增加植物产量的方法。
• Fluorinated derivatives of deferiprone
  申请人：Tam Tim Fat

  公开号：US20080242706A1

  公开（公告）日：2008-10-02

  The present invention relates to novel derivatives of deferiprone. In particular, the present invention relates to fluorinated derivatives of deferiprone or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, processes for the manufacture thereof and their use in the treatment of neurodegenerative diseases caused by the presence of free iron or iron accumulation in neural tissues and in diseases wherein excess iron must be removed or redistributed.

  本发明涉及延胜肽的新颖衍生物。具体地，本发明涉及延胜肽的氟化衍生物或其药用盐，包括相同的药物组成部分，制造这些药物组成部分的方法以及它们在治疗由游离铁或神经组织中铁积累引起的神经退行性疾病以及需要去除或重新分配过量铁的疾病中的用途。
• [EN] SELENOPHENE AND SELENAZOLE CARBOXYLIC ACID DERIVATIVES<br/>[FR] DÉRIVÉS D'ACIDES SÉLÉNOPHÈNE ET SÉLÉNAZOLE CARBOXYLIQUES
  申请人：IRONWOOD PHARMACEUTICALS INC

  公开号：WO2009148564A1

  公开（公告）日：2009-12-10

  Derivatives of selenophene and selenazole heterocycles are disclosed. The compounds are useful as inhibitors of D-amino acid oxidase (DAO) and in the treatment of neurodegenerative and psychiatric diseases and disorders.

  本文披露了硒吲哚和硒唑杂环的衍生物。这些化合物可用作D-氨基酸氧化酶（DAO）的抑制剂，并用于治疗神经退行性和精神疾病和障碍。
• New phosphoramide derivatives
  申请人：Almansa Rosales Carmen

  公开号：US20060111326A1

  公开（公告）日：2006-05-25

  New phosphoramide derivatives of formula (I) and the salts and solvates thereof, wherein the meanings of the various substituents are as disclosed in the description. Said compounds are useful as antiinflammatory and analgesic agents.

  新的磷酰胺衍生物公式(I)及其盐和溶剂化物，其中各种取代基的含义如说明中所述。这些化合物可用作抗炎和镇痛剂。
• ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME
  申请人：Ensinger Carol L.

  公开号：US20090221821A1

  公开（公告）日：2009-09-03

  The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A 1 receptor. Adenosine A 1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable. In one embodiment, the invention features a compound of formula I:

  该发明基于发现，公式I化合物是意外地高效和选择性地抑制腺苷A1受体的抑制剂。腺苷A1拮抗剂可用于预防和/或治疗许多疾病，包括心脏和循环系统疾病，中枢神经系统退行性疾病，呼吸系统疾病以及许多适合利尿治疗的疾病。在一种实施例中，该发明涉及公式I的化合物：

表征谱图